Latest News & Updates of Loncom Pharma

Celebrating Shandong Loncom Pharmaceutical's Fezolinetant and Dotinurad Receiving WC Certificates

Shandong Loncom, proudly announces the launch of three high-potential star products: Abrocitinib, Ritlecitinib Mesylate, and Iptacopan (For Research Use Only).

Recently, the Biocom team traveled to Seoul, South Korea, to participate in CPHI Korea 2025, the World Pharmaceutical Ingredients Exhibition. During the event, the team engaged with global pharmaceutical industry leaders to explore collaborative opportunities.

Quitting smoking is one of the most challenging health decisions many people face. Nicotine addiction is powerful and affects the brain’s reward pathways, making cessation difficult due to intense cravings and withdrawal symptoms. Fortunately, advances in pharmacology have led to the development of medications designed to ease this transition. One such medication that has gained widespread attention and proven efficacy is Varenicline Tartrate.